Midodrine - A Review of its Pharmacological Properties and Therapeutic Use in Orthostatic Hypotension and Secondary Hypotensive Disorders

Drugs

Volumn 38, Issue 5, 1989, Pages 757-777

  McTavish, Donna ^a   Goa, Karen L ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 (2,5 DIMETHOXYPHENYL)ETHANOL; DIHYDROERGOTAMINE; DIMETOFRINE; DRUG METABOLITE; EPHEDRINE; ETILEFRINE; MIDODRINE; NORFENEFRINE;

CLINICAL ARTICLE; DRUG ABSORPTION; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; REFLEX; REVIEW; SIDE EFFECT; SUPINE HYPOTENSION SYNDROME; URINE LEVEL;

ANIMAL; ETHANOLAMINES; HUMAN; HYPOTENSION, ORTHOSTATIC; MIDODRINE;

EID: 0024385133     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198938050-00004     Document Type: Article

References (37)

1. A new approach to the diagnosis and treatment in out-patients of orthostatic hypotension
2. Investigations of the effect of midodrine on carbohydrate and fat metabolism with particular reference to the diabetic metabolic state
3. Midodrine in the treatment of orthostatic hypotension
4. The use of a new alpha-adrenergic drug in the treatment of essential hypotension: results of a controlled clinical trial
5. Studies on the peripheral hemodynamics in man after intravenous infusion of a small dose of dl-l-(2′,5′-dimethoxyphenyl)-2-glycinamidoethanol-(1)-hydrochloride (= ST 1085)
6. Comparative studies and evaluation of the therapeutic usability of midodrin (Gutron.®) in the hypotension syndrome
7. Studies on the bioavailability of midodrine and α-2,5-dimethoxyphenyl- β-aminoethanol hydrochloride
8. The use of midodrine in the treatment of the orthostatic syndrome
9. Treatment of hypotension caused by psychopharmacological drugs. A double-blind study
10. Hemodynamic effects of a new substance (2′-5′-dimethoxyphenyl-2-glycinamidoethanol-1-hydrochloride) after intravenous administration
11. The modification of neuroleptic-induced hypotension by a new alpha-sympathomimetic drug
12. What can a circulatory agent do for patients paralysed by a transverse lesion of the cord?
13. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)
14. Tolerance studies of the alpha-sympathomimetic Gutron®
15. Treatment of hypotensive circulatory dysregulation in practice with GUTRON
16. Comparative clinical study on an antihypotensive therapy with Gutron® and a depot preparation. Dr
17. The pharmacological properties of midodrin and its clinical application in patients with hypotensive circulatory disturbance
18. Autoradiographic studies of the uptake and accumulation of Gutron®
19. Therapeutic effect of midodrine in hypotensive orthostatic circulatory dysregulation
20. The activity of midodrine in orthostatic circulatory dysregulation
21. Clinical drug evaluation. Use of Gutron® (midodrine) in the treatment of arterial hypotension syndrome
22. Subarachnoid anesthesia and midodrine
23. Controlled clinical investigation of dimetophrine versus midodrine in the management of moderately decreased arterial blood pressure
24. Experimental and clinical experience with a new sympathicomimetic (2′,5′-dimethoxyphenyl -2-glycinarnido-ethanol-1-hydrochloride)
25. Pharmacodynamic actions of midodrine, a new α-adrenergic stimulating agent, and its main metabolite, ST 1059
26. Diagnosis and therapy of hypotensive disturbances in the circulatory regulation in general practice
27. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome
28. Studies on the effect of the alpha-receptor stimulant, GutronR, in the orthostatic syndrome
29. The effect of midodrine on orthostatic hypotension
30. Pathophysiological classification and diagnosis of orthostatic hypotension
31. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins
32. Correction of severe orthostatic hypotension by midodrine: a new alpha adrenoceptor agonist. Abstract
33. Infectious-toxic hypotension — effect and dosage of midodrine
34. Pharmacodynamics of midodrine, an antihypotensive agent